However, since HepG2 cells are a hepatocellular carcinoma cell line, it is possible that the mechanism leading to viral-mediated reduction in PLSCR1 expression may be similar to what we observed in our ovarian carcinoma cell lines treated with dsDNA (Fig. 5A). The gene discussed is PLSCR1; the disease is ovarian carcinoma.